Bimekizumab for treating ankylosing spondylitis TS ID 10334Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Inebilizumab for treating AQP4-IgG seropositive neuromyelitis optica spectrum disorders ID6430Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Troriluzole for spinocerebellar ataxia ID 6456Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Neuro-Cells stem-cell treatment for traumatic spinal cord injury [TS ID 12048]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC